Trials / Unknown
UnknownNCT00000349
Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
Infusion Laboratory: Protocol 5 (Flupenthixol)
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 21 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate clinical safety issues pertaining to flupenthixol, to cocaine, and to their interaction, and to determine how pretreatment with flupenthixol modifies the subjective as well as physiological effects of cocaine. Taken together, these relatively D-1 selective agents can help determine the extent to which DA-1 binding affects the reinforcing effects of stimulants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flupenthixol |
Timeline
- First posted
- 1999-09-21
- Last updated
- 2017-01-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000349. Inclusion in this directory is not an endorsement.